BusinessThe Celiac Disease Foundation Appoints New Member to Board of DirectorsBy Nasdaq OMXFeb 13, 2018, 1:00 PM UTC
BusinessInnovate Biopharmaceuticals’ Dose Response Data for Larazotide Acetate Demonstrating Its Unique Mechanism of Action and Applications in Diseases Caused by Increased Intestinal PermeabilityBy Nasdaq OMXDec 28, 2017, 2:00 PM UTC
BusinessInnovate Biopharma’s Pediatric Ulcerative Colitis Drug Granted FDA Orphan DesignationBy Nasdaq OMXSep 6, 2017, 9:06 PM UTC
BusinessInnovate Biopharmaceuticals Submits Orphan Drug Application to FDA for Pediatric Ulcerative Colitis IndicationBy Nasdaq OMXJul 12, 2017, 11:07 AM UTC
